C. Carroll

发表

A statistical-based approach to assessing the fidelity of combinatorial libraries encoded with electrophoric molecular tags. Development and application of tag decode-assisted single bead LC/MS analysis.

W. Egan, J. Reader, M. Orlowski, 2000, Journal of combinatorial chemistry.

Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors.

A. Stamford, J. Cumming, L. Zhang, 2008, Bioorganic & medicinal chemistry letters.

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold.

James W. Hall, J. Baldwin, C. Carroll, 2011, Bioorganic & medicinal chemistry letters.

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.

C. Carroll, D. Hobbs, B. Mcguinness, 2014, Bioorganic & medicinal chemistry letters.

Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.

I. Gluzman, D. Goldberg, M. Orlowski, 1998, Bioorganic & medicinal chemistry letters.

Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges

Maria L Webb, M. Webb, C. Carroll, 2008 .

II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.

James W. Hall, C. Carroll, D. Hobbs, 2011, Bioorganic & medicinal chemistry letters.

Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.

I. Gluzman, D. Goldberg, M. Orlowski, 1998, Bioorganic & medicinal chemistry letters.

Screening aspartyl proteases with combinatorial libraries.

M. Orlowski, C. Carroll, 1998, Advances in experimental medicine and biology.

Novel CXCR3 antagonists with a piperazinyl-piperidine core.

James W. Hall, B. Jacob-Samuel, C. Carroll, 2009, Bioorganic & medicinal chemistry letters.

Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges.

M. Webb, C. Carroll, K. Appell, 2008, Expert opinion on therapeutic targets.